The octapeptide, angiotensin II, elicits a positive inotropic response in myocardial tissue by activating slow calcium channels. Pharmacological studies suggest that the inotropic action of angiotensin II is receptor mediated. The current investigation was performed to characterize the binding of 12:> I-angiotensin II to the putative receptor in a plasma membranesarcoplasmic reticulum preparation of the rabbit left ventricle. In experiments performed at 18°C, steady state binding occurred at 45 minutes and saturable binding was 80-85% of the total binding. Analysis of the binding data indicated that the '^I-angiotensin II interacted with a single class of sites with a Kj = 4.5 ± 0.8 nM and exhibited a binding capacity of 53.5 ± 8 fmol/mg protein. The potency order for the competitive binding of analogues and antagonists of angiotensin II paralleled that observed for in vitro contractile force development in bioassay systems utilizing left atrial tissue. The binding of U:> I-angiotensin II was stimulated 2-fold in the presence of the divalent cations of calcium and magnesium (10 HIM). Guanine nucleotides modified the binding of 12 "I-angiotensin II to the rabbit myocardial particulate fraction. Guanine triphosphate and nonhydrolyzable analogues of guanine triphosphate increased the dissociation rate of the bound l2 M-angiotensin II and decreased hormone binding to the receptor at equilibrium. In the absence of magnesium, guanine nucleotides had no effect on the dissociation rate of 125 Iangiotensin II. '-*I-Angiotensin II binding to a rabbit myocardial particulate fraction was found to have high affinity, to be saturable, reversible, specific, and modulated by guanine nucleotides. The characteristics of the binding site of l25 I-angiotensin II indicate that it is the hormone receptor which mediates the physiological (inotropic) effects of angiotensin II in rabbit myocardial tissue (Circ Res 54: 286-293, 1984) 
SUMMARY. The octapeptide, angiotensin II, elicits a positive inotropic response in myocardial tissue by activating slow calcium channels. Pharmacological studies suggest that the inotropic action of angiotensin II is receptor mediated. The current investigation was performed to characterize the binding of 12:> I-angiotensin II to the putative receptor in a plasma membranesarcoplasmic reticulum preparation of the rabbit left ventricle. In experiments performed at 18°C, steady state binding occurred at 45 minutes and saturable binding was 80-85% of the total binding. Analysis of the binding data indicated that the '^I-angiotensin II interacted with a single class of sites with a Kj = 4.5 ± 0.8 nM and exhibited a binding capacity of 53.5 ± 8 fmol/mg protein. The potency order for the competitive binding of analogues and antagonists of angiotensin II paralleled that observed for in vitro contractile force development in bioassay systems utilizing left atrial tissue. The binding of U:> I-angiotensin II was stimulated 2-fold in the presence of the divalent cations of calcium and magnesium (10 HIM). Guanine nucleotides modified the binding of 12 "I-angiotensin II to the rabbit myocardial particulate fraction. Guanine triphosphate and nonhydrolyzable analogues of guanine triphosphate increased the dissociation rate of the bound l2 M-angiotensin II and decreased hormone binding to the receptor at equilibrium. In the absence of magnesium, guanine nucleotides had no effect on the dissociation rate of 125 Iangiotensin II. '-*I-Angiotensin II binding to a rabbit myocardial particulate fraction was found to have high affinity, to be saturable, reversible, specific, and modulated by guanine nucleotides. The characteristics of the binding site of l25 I-angiotensin II indicate that it is the hormone receptor which mediates the physiological (inotropic) effects of angiotensin II in rabbit myocardial tissue (Circ Res 54: 286-293, 1984) ANGIOTENSIN II (All) induces a contractile response in both smooth muscle and cardiac tissue. The positive inotropic response that occurs in cardiac tissue has been described in several species, including the dog, cat, and rabbit (Fowler and Holmes, 1964; Dempsey et al., 1971; Koch-Weser, 1964; Koch-Weser, 1965; Illanes et al., 1967) . Pretreatment with reserpine (Fowler and Holmes, 1964; Illanes et al., 1967; Koch-Weser, 1965; Lefer, 1967) , acetylcholine (Peach, 1981) , ;8-adrenergic antagonists (Koch-Weser, 1964) , or extrinsic cardiac denervation (Dempsey et al., 1971) does not affect the inotropic response to All. These observations suggest that the hormone exerts a direct myocardial effect that is independent of the /3-adrenergic system. In addition, cAMP accumulation induced by isoproterenol and basal adenylate cyclase activity are not affected by All, providing evidence that the inotropic effects of All on cardiac tissue are independent of cAMP accumulation (Peach, 1981) . The All-induced contractile response in rabbit ventricle is preceded by a slow-rising action potential (Freer et al., 1976) which is blocked by Mn T ' r , La ++ , and verapamil, but not by tetrodotoxin. These results suggested that the inotropic response was in part related to augmentation of the slow inward Ca ++ current (Peach, 1981) . The All-induced slow rising action potential was blocked by [Sar 1 , Ile*]-angiotensin II. Comparable studies have been reported for chick ventricle and bovine Purkinje fibers (Freer et al., 1976; Rioux et al., 1976; Bonnardeaux and Regoli, 1974) . All of these findings provide evidence that the cardiac actions of All are due to receptor-mediated increases in Ca ++ influx. Robertson and Khairallah (1971) have also demonstrated an effect of All on protein synthesis in the heart, including localization of 3 Hangiotensin in the nuclei of cardiac muscle cells.
Receptors for All have been characterized in numerous tissues including vascular smooth muscle (Devynck and Meyer, 1978; Gunther et al., 1982) , smooth muscle (Capponi and Catt, 1980) , adrenal cortex (Glossman et al., 1974) , kidney (Beaufils et al., 1976; Freedlender and Goodfriend, 1977) , brain (Bennett and Snyder, 1976) , liver , and heart (Lin and Goodfriend, 1970) . In this study, we report the characterization of the I2 -I-AII binding sites in a rabbit myocardial membrane preparation. The All binding sites in this preparation had high affinity, were saturable, reversible, specific, and modulated by divalent cations and guanine nucleotides. The binding and competition by an agonist/ antagonist analogue series correlated with their inotropic activities in the bioassay. The data suggest that these binding sites represent the receptors which mediate the positive inotropic effects of All in the heart. Methods 125 1-Angiotensin II (specific activity, 1880 jiCi/Vg) was obtained from New England Nuclear Corporation. Angiotensin II, angiotensin I, angiotensin III, and the angiotensin antagonist analogues were obtained from United States Biochemical Corporation and Peninsula Laboratories.
[Sar 1 ]-Angiotensin II and [Sar',Ala 7 ]-angiotensin II were kindly supplied by Dr. Mahesh Khosla of the Cleveland Clinic. Guanine nucleotides were obtained from Boehringer-Manheim Biochemicals. Protein determinations were performed by the method either of Lowry et al. (1951) or of Bradford et al. (1976) . All other chemicals and reagents were obtained from Fischer Scientific Corporation or Sigma Chemical Company. Number 30 glass fiber filters (25 mm in diameter) were purchased from Schleicher and Schuell.
Rabbit myocardial or atnal membranes were prepared from 2-to 3-kg, male, New Zealand white rabbits, by a modification of the original protocol of Harigaya and Schwartz (1969) , as described by Jones et al. (1979) . The animals were killed by concussion, the hearts removed immediately, and the left atrium or left ventricle dissected free and cut into 3-to 4-mm pieces. A homogenate of the left atrium or left ventricle (20% weight:volume) was prepared in 0.25 M sucrose, 25 mM Tris, at pH 7.5 (on ice) with a Brinkman Polytron, using a PT-20 probe at a setting of 5'/2 for 30 seconds X two. The homogenate was sedimented at 10,000 g for 20 minutes. The pellet was screened for binding and the supernatant was decanted and sedimented at 45,000 g for 30 minutes. The pellet was resuspended in 10 ml of 0.6 M KC1 and 30 mM histidine at pH 7.0 to solubilize acrin and myosin filaments, and resedimented at 45,000 g for 30 minutes to yield the crude membrane vesicles. The yield was approximately 1 mg of protein/g of heart. All centrifugations were performed at 5°C. The membranes were used immediately because their ability to bind 125 I-AII decreased with storage. The initial 45,000 g supernatant was centrifuged at 105,000 g for 1 hour, and the pellet was resuspended and screened for binding sites. Comparable 125 I-AII binding data were obtained for the left atrium and left ventricle. Therefore, subsequent binding experiments were performed using left ventricular myocardium because of the larger amount of tissue available, while the atrium was used for pharmacological studies (see below).
The pellets obtained from the final centrifugations were washed three times and resuspended in the binding buffer (Tris, 25 mM; MgCl 2 , 10 mM; bacirracin, 10 ^g/ml; dithiothreitol, 5 X 10" 4 M; and crystalline bovine serum albumin (BSA), 0.2%; at pH 7.5). For experiments testing the effect of ions on 125 I-AII binding to the particulate fraction, membranes were prepared in the same buffer, except for the deletion of MgCl 2 and the addition of EDTA (10' 4 M).
The concentration of I25 I-AII was 0.30 to 0.35 nM in all of the binding experiments. For the binding isotherms, unlabeled hormone was added to the 125 I-AII to achieve the higher concentrations of the ligand. Time course studies were done to define the equilibrium conditions for the range of hormone concentrations used in the saturationbinding isotherms. The binding reaction was initiated by the addition of the myocardial particulate fraction (40 y\;
1.5 mg of protein/ml, final concentration) and incubated in a total volume of 0.1 ml of assay buffer for 60 minutei at 18°C (all experiments were performed at this temperature, unless otherwise specified) in 12 X 75 mm polypropylene tubes (Fisher Scientific). Following incubation, 4 ml of ice-cold 25 mM Tris at pH 7.5 were added to the assay tube, and bound and free hormone were separated by filtration, using glass fiber filters that had been presoaked in a 0.2% solution of fraction V BSA. This was followed by a 4-ml rinse of the incubation tube and 2 x 4 ml rinse of the filters with Tris (25 mM, 4°C). The filters were dried in room air, and bound radioactivity was determined by counting in a Beckman Biogamma Counter with an efficiency for '"'I of 40%. Experimental results are expressed as saturable binding, defined as that portion of total binding able to be displaced by 10~5 M unlabeled ligand.
Metabolism of 125 I-AII during the binding assays was assessed by thin layer chromatography (TLC). I-AII (0.35 nM) was incubated with membranes (total volume, 100 (A; membranes, 40 nl) at a concentration of 1.5 mg of protein/ml for 60 minutes at 18°C. Bound and free ligand were separated by centrifugation. The bound hormone was solubilized by adding 100 fi\ of 50% glacial acetic acid to the pellet, followed by incubation in a boiling water bath for 5 minutes. The free and bound hormone were spotted on Eastman Kodak plastic-backed cellulose TLC plates and developed in a solvent of n-butyl alcohol:acetic acid:pyridine:water (15:3:10:12). The plates were scanned with a Berthold thin layer radio scanner, as well as cut into 1 cm 2 strips and counted in a Beckman Biogamma Counter. The TLC standard on each chromatogram was the native 125 I-AII.
The left atria were prepared for inotropic studies by the method of Blumberg et al. (1975) . The point-stimulated preparations were electrically paced at 1 Hz, at 2X threshold voltage. The atria were connected to Grass FT 03 C force displacement transducers and allowed to contract isometrically. Each preparation was maintained at maximum length (about 4.5 g resting tension). The atria were placed in buffer (10 ml) containing NaCl, 119 mM; CaCl 2 , 2.54 mM; KC1, 4.7 mM; NaH 2 PO 4 , 1.18 mM; MgCl 2 , 0.5 mM; NaHCO 3 , 25 ITIM; and glucose, 5.5 mM. The bath temperature was maintained at 37°C, and the chambers were gassed with 95% O 2 /5% CO 2 . Contractions were monitored for each preparation on Brush or Grass recorders. All of the peptides used in the binding experiments were studied in vitro for inotropic activity. Force generation by angiotensin I was determined in the absence and presence of the converting enzyme inhibitor teprotide (10ng/ml).
K,Na-ATPase activity was assessed by the method of Matsui and Schwartz (1966) . Inorganic phosphate was measured by the method of Fiske and Subarrow (1925) . Utilizing the method of Anson (1937) , lysosomal enzyme (cathepsin D) activity was determined spectrophotometrically. Mitochondrial monoamine oxidase activity was determined by the method of Buffoni and Blashko (1971) .
The affinities and number of binding sites for the saturation binding isotherms were determined using a nonlinear least squares curve-fitting program to fit the data to a one-or two-site model (Johnson et al., 1976) . Data were also transformed to a Scatchard plot (Scatchard, 1949) . Binding parameters are expressed as mean values ± SEM. All other data are expressed as mean values ± SEM, unless otherwise specified.
Results
Preliminary experiments were carried out to define the stability, temperature and ion dependence, and kinetics of '""I-All binding to the rabbit myocardial particulate fractions. Chromatography of the 125 I-AII bound and labeled peptide(s) in the medium demonstrated that degradation of the radioligand was prevented or attenuated (depending on the membrane fraction utilized) in this buffer. Little or no saturable binding was observed with the 10,000 g or 105,000 g pellets (data not shown). Cathepsin D activity indicated that there was no protease activity against hemoglobin in the final 45,000 g supernatant or pellet, suggesting that lysosomal disruption was not a problem in membrane isolation procedures. Monoamine oxidase activity (MAO) was used as the mitochondrial marker, and there was <0.1% MAO activity remaining in the final 45,000 g pellet. The activity of the plasma membrane marker, ouabain-inhibited Na + ,K + -AT-Pase, was comparable to that reported by Jones et al. (1979) and indicated that the final 45,000 g pellet was an enriched fraction of plasma membrane-sarcoplasmic reticulum.
The binding of 12r "I-AII to the 45,000 g myocardial particulate fraction increased linearly with protein concentrations between 25 and 200 jig/100 ul (Fig. 1) . The binding of 125 I-AII to the 45,000 g atrial particulate fraction also increased linearly with protein concentrations between 25 and 150 Mg/ul (data not shown). Figure 2 shows the rate of association and maximal binding of 12:> I-AII as a function of time and temperature. The stability of binding was inversely related to the temperature of incubation. At 24°C, binding began to decrease after equilibrium was reached. At 18°C, equilibrium binding remained stable from 45 to 90 minutes.
The concentration-dependent binding of I25 I-AJI to the rabbit myocardial particulate fraction is shown in Figure 3A . The binding isotherm spans more than three orders of magnitude with a threshold concentration approximating 10~1 0 M All and saturation of sites occurring at 10~7 M All. When the data were transformed according to Scatchard, the plot suggested the presence of a single class of binding sites (Fig. 3B ). Computer analysis of the saturation-binding data yielded an optimal fit to a one-site model with a high affinity site Kd = 4.5 ± 0.8 nM and number of sites (n) = 53.3 ± 8 fmol/mg of protein.
Comparable binding affinity of 125 I-AII (Kd = 5 nM) was observed in the left atrial 45,000 g particulate fraction. However, the number of sites (n = 400 fmol/mg of protein) was higher in the atrial preparation. Based on the trace amounts of ligand used in this study, a low affinity site may not have been detected with the high affinity site, and the need for additional studies with 3 H-AII is indicated.
Competition by angiotensin peptides with 125 I-AII binding to the rabbit myocardial particulate fraction is shown in Figure 4B . The displacement curves for [Sar']-angiotensin II and [Sar 1 ,Ile 8 ]-angiotensin II were shifted to the left of flle 5 l-angiotensin II by approximately 5-fold. Angiotensin III and [Sar 1 ,Ala ] -angiotensin II were equipotent with [Ile'j-angiotensin II in displacing 125 I-AII. [Sar , Ala 7 ]-angiotensin II was 15% as potent as the native hormone in competing for binding. Angiotensin I was approximately 1% as potent as [Ile 5 ]-angiotensin II in inhibiting the binding of 125 I-AII. Displacement of I2:I I-AII bound to rabbit atrial and ventricular particulate fractions by All was identical in the two tissues (data not shown). Biological activities for the agonist analogues on atrial contractions are shown in Figure 4A . The order of potency was [Sar']-AII > All > AIII > [Sar 1 , Ala 7 ]-AII > AI. The ED 50 (k acts ) and IC 50 (Kd-j.) values are compared in Table 1 . The binding of 125 I-AII to the myocardial particulate fraction was determined in the presence of various cations. These experiments were performed with a particulate fraction prepared and washed several times in binding buffer that contained Tris, 25 mM; EDTA, 10"" M; baritrarin, 10 Mg/ml; dithiothreitol, 5 X 10"" M; and crystalline BSA, 0.2%; at a pH of 7.5. At concentrations of free ion of 10 mM, the divalent cations Mg ++ and Ca ++ stimulated maximal I25 I-AII binding approximately 2-fold over control levels. The binding of 125 I-A1I was decreased in the presence of the monovalent cations, K + and Na + (Fig. 5) .
Guanine nucleotides accelerated the dissociation rate of 125 I-AII from the myocardial particulate fraction. As shown in Figure 6 , both Gpp(NH)p and GTP-7-S increased the dissociation rate of I25 I-AII by unlabeled All from the binding sites. In the absence of Mg ++ , Gpp(NH)p and GTP-7-S had no effect on the dissociation rate of the 125 I-AII from the binding sites (Fig. 6) . A semilog plot of these data revealed two rates of dissociation. The guanine nucleotides appeared to induce a transition to a lower affinity state.
Discussion
In this study, we have characterized the binding of 125 I-AII in a particulate fraction of plasma membrane and sarcoplasmic reticulum of the rabbit left atrium and left ventricle and provided evidence that these binding sites are the putative receptors that mediate the cardiac responses to AIL The binding of 123 I-AII in this preparation was saturable (Fig. 3) , reversible (Fig. 6) , specific (Fig. 4B ), of high affinity (Fig. 3) and correlated with the biological effects of the hormone analogs ( Fig. 4A; Table 1 ). Angiotensin III was almost as potent as [Ile 5 ]-angiotensin II in displacing 125 I-AII from the receptor. The kj of angiotensin III was in contrast to its in vitro inorropic activity, where it was 20-30% as potent as All. The difference may be due to an absence of degradation of angiotensin III in this membrane preparation, compared to the degradation which occurs in iso lated tissue, or it may be due to the different temperatures of incubation. The k^ and K act values for angiotensin I were also different by half an order of magnitude, which may reflect a difference in converting enzyme activity in the membranes vs. intact atria ( Table 1) . [Sar 1 , Ala 7 ]-All was selected from a group of cardioselective angiotensin analogs * Responses were obtained in the presence of 10 Mg/ml teprohde.
t A partial agonist in cardiac tissue. J Molar concentration of antagonist required to completely block the inorropic response induced by an ED M concentration of angiotensin II. (Trachte et al., 1981) , and we found good agreement between the kd and k acl values for this peptide. The kj•" and dissociation curves for the displacement of I25 I-AII by unlabeled All were the same in the particulate fraction obtained from either left atrium or left ventricle. However, the amount of I2j I-AII bound per mg protein was higher in the atrial preparation vs. ventricle. Left ventricular myocardium was used because of the larger amount of tissue available and the increased protein yield.
Our data are consistent with one class of All binding sites. A single class of sites has been identified in vascular and nonvascular smooth muscle (Gunther et al., 1982; Hauger et al., 1982) , brain (Bennett and Snyder, 1976) , and heart (Mukherjee, 1982) . However, two classes of binding sites have been demonstrated in tissue from the adrenal gland (Glossman et al., 1974) , liver , and the kidney (Beaufils et al., 1976; Freedlender and Goodfriend, 1977) . Wright et al. (1983) have characterized the angiotensin II receptor in a rabbit ventricular myocardial particulate fraction. Those authors found a high-and low-affinity site (K D i = 0.42 nM and K D 2 = 104 nM). When compared to our results, there are both technical differences and differences in the membrane preparation that may account for the disparate findings. In cells from embryonic chick heart, high and low affinity All binding sites have also been identified. The low affinity site (K 2 = 100 nM) was present as early as day 4 in ovum, and was coupled to a mechanical response. By day 14, a high affinity site (Ki = 0.5 nM) was present with the low affinity site (Peach, unpublished) . The two-component exponential displacement curve seen in the presence of GTP in this preparation is consistent with a transition to a lower affinity state which has been reported for GTP interactions with other ligands.
In the studies on the All binding sites in adrenal (Glossman et al., 1974) , kidney (Sraer et al., 1974) and brain (Bennett and Snyder, 1976) , there was significant metabolism of the labeled All, necessitating the inclusion of protease inhibitors, disulfidereducing agents, and unrelated peptides in the assay buffer to prevent degradation. However, dithiothreitol has been shown to interfere with All binding to plasma membranes of vascular smooth muscle (Gunther et al., 1980) . In the present study, some degradation of the UD I-A\1 occurred when bacitracin and dithiothreitol were not included in the assay buffer. Prevention of degradation was possible by combining these two agents, whereas higher concentrations of either bacitracin (>10 ^g/ml) or dithiothreitol (>5 x 10" 4 M) alone interfered with binding.
In several tissues (heart, liver, adrenal, smooth muscle, and kidney), All has been shown to have an effect on the movement of ions (Freer et al., 1976; Freedlender and Goodfriend, 1977; Blackmore et al., 1979; Brock et al., 1982; Elliot et al., 1981) . Various ions also have been shown to affect the interaction of All with its receptors Gunther et al., 1980; Cart et al., 1974; Bennett and Snyder, 1980) . In cardiac tissue, the inorropic response to All was found to be related to an increase in the permeability of the cell membrane to Ca ++ during the action potential (Freer et al., 1976) . In the present study, the divalent cations Mg ++ and Ca ++ potentiated the binding of the 125 I-AII to the rabbit myocardial particulate fraction. We have shown, in this preparation, that the interaction of the receptor with guanine nucleotides required a divalent cation. The dissociation of bound 125 I-AII by All in the presence and absence of guanine nucleotides exhibited divalent cation dependence. Without Mg ++ or Ca ++ , the rate constant for the dissociation of bound 125 I-AII by unlabeled All was very slow (tVi > 2 hrs), either in the absence or presence of guanine nucleotides. The biphasic 12j I-AII dissociation curve with Mg ++ and guanine nucleotides argues for a change in affinity states of the receptor. The initial dissociation rate constant of bound 125 I-AII was increased markedly by guanine nucleotides; however, there was a transition into a second, much slower dissociation rate that approached equilibrium during the experimental protocol (Fig. 6) . Experiments have been carried out for longer periods of time, but beyond 90 minutes, significant metabolism of the 1 I-All has occurred. Whether the ionic require-merits for the peptide-receptor interaction merely reflected the ionic requirements for the interaction of a guanine nucleoride regulatory protein with the membrane receptor is not known. It appeared that, in cardiac tissue, divalent cations were important not only for the contractile response to AH but also for peptide-receptor and/or receptor-guanine nucleotide-regulatory protein interactions.
Guanine nucleotides have been shown to accelerate the rate of dissociation of agonist hormonesreceptor complexes that are either positively or negatively linked to adenylate cyclase activity and cAMP accumulation. In the liver and kidney, AH did not stimulate membrane adenylate cyclase, raise cellular cAMP levels, or activate cAMP-dependent protein kinase. However, in the liver and renal cortex, All has been shown to inhibit adenylate cyclase and glucagon-(liver) and PTH-(renal cortex) stimulated cAMP accumulation Woodcock et al., 1982) . In cardiac tissue, there is no evidence that All affects adenylate cyclase activity or the accumulation of cAMP. Basal adenylate cyclase activity and isoproterenol-stimulated cAMP accumulation are not affected by All. Also, the inotropic activities of All were additive with 0-adrenergic agonists and were not inhibited by acetylcholine (Peach, 1982) . The negative inotropic effects of acetylcholine have been correlated with inhibition of activation of adenylate cyclase. However, we have demonstrated a GTP-induced modulation of the binding of 125 I-AII to the rabbit myocardial particulate fraction, and, for this reason, further studies on the interaction of AH with adenylate cyclase in myocardial tissue seem warranted.
In conclusion, we have presented data describing the binding of I25 I-AII to a rabbit myocardial membrane fraction. These binding sites exhibited the properties expected of a hormonal receptor and probably represent the receptors that interact with All to mediate the cardiac contractile response to this peptide. The characterization of this receptor should facilitate further study of the physiological actions of All in cardiac tissue in both normal and pathological states.
